Close

Epizyme (EPZM) PT Raised to $27 at Oppenheimer

July 9, 2018 8:05 AM EDT Send to a Friend
Oppenheimer raised its price target on Epizyme (NASDAQ: EPZM) to $27.00 (from $25.00) while maintaining a Outperform rating.Analyst Leah Rush ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login